首页> 外文期刊>Journal of Xi'an Medical University >THE CHANGES OF PERIPHERAL BLOOD T LYMPHOCYTE SUBSETS IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA BOTH PRE-TACE AND POST-TACE
【24h】

THE CHANGES OF PERIPHERAL BLOOD T LYMPHOCYTE SUBSETS IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA BOTH PRE-TACE AND POST-TACE

机译:原发性肝癌和肝癌后患者原发性肝癌患者外周血T淋巴细胞亚群的变化

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To observe the variations of the cellular immunological function in patients with primary hepatic carcinoma both pre-TACE (transcatheter arterial chemoembolization, TACE). Methods T lymphocyte subset CD4, CD8 and CD4/CD7 ratio in 45 patients with primary hepatic carcinoma both pre-TACE and post-TACE were measured by flow Cytometer, and compared with the result of T lymphocyte subset in 19 healthy people as normal control samples. Results The CD4 and CD4/CD8 ratio in patients with primary hepatic carcinoma were significantly lower than those in normal control (P<0.05), while CD8 higher (P<0.05); The CD4 and CD4/CD8 ratio in patients with primary hepatic carcinoma were much more lower after TACE than those before TACE (P < 0.05), while CD8 was higher but had no significant difference (P>0.05). Conclusion The cellular immunological function in patients with primary hepatic carcinoma decreased and is much more lower after TACE.
机译:目的观察原发性肝癌患者在TACE前(经导管动脉化疗栓塞,TACE)的细胞免疫功能变化。方法采用流式细胞仪检测45例原发性肝癌患者在TACE前后的T淋巴细胞亚群CD4,CD8和CD4 / CD7比值,并与正常对照组19例健康人的T淋巴细胞亚群结果进行比较。 。结果原发性肝癌患者CD4和CD4 / CD8比值明显低于正常对照组(P <0.05),而CD8较高(P <0.05); TACE后原发性肝癌患者的CD4和CD4 / CD8比值显着低于TACE前(P <0.05),而CD8较高但无显着性差异(P> 0.05)。结论TACE后原发性肝癌患者的细胞免疫功能下降,且免疫功能明显降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号